gefitinib has been researched along with oxyquinoline in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (oxyquinoline) | Trials (oxyquinoline) | Recent Studies (post-2010) (oxyquinoline) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,623 | 28 | 363 |
| Protein | Taxonomy | gefitinib (IC50) | oxyquinoline (IC50) |
|---|---|---|---|
| Botulinum neurotoxin type A | Clostridium botulinum | 3.9 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 2.3736 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 2.9667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
1 other study(ies) available for gefitinib and oxyquinoline
| Article | Year |
|---|---|
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |